Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
Clinical trial NCT03946111 · COMPLETED
Trial details
- NCT number
- NCT03946111
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-07
- Primary completion
- 2024-12-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.